Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Elraglusib | 1034895-42-5 | ≥98.0% | 404.35 g/mol | C22H13FN2O5 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1139145MG

Encompass_Preferred

9-ING-41 (Elraglusib) is a maleimide-based, ATP-competitive selective inhibitor of glycogen synthase kinase-3β (GSK-3β) used in preclinical research to study signaling pathways, apoptosis, autophagy, and antitumor activity. It is provided as a small-molecule powder for laboratory use.

  • Selective GSK-3β inhibitor with reported IC50 of 0.71 μM.
  • Induces cell cycle arrest, apoptosis, and autophagy in cancer cells.
  • Suitable for in vitro and in vivo research as a small-molecule powder.
  • Molecular formula C22H13FN2O5; molecular weight 404.35 g/mol.
  • Recommended storage: powder at -20°C for long-term stability.

Catalog No. 50-002-63889


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.